Enforce Medical Technologiessp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-09-01. Active
54 1600 1462 1082 0447 9000 0007- 36 1750 1019 0000 0000 4110 4791
- 38 1750 1019 0000 0000 3848 1002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
9 public aid cases recorded, with a total value of $1,886,344.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 25, 2026 | Aid for research and development projects: experimental development | $406.6K$406,583 | Marszałek Województwa Wielkopolskiego | |
| Feb 25, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $14,749$14,749 | Marszałek Województwa Wielkopolskiego | |
| Dec 14, 2021 | Aid for research and development projects: industrial research | $418.7K$418,706 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $1,578,890.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-01-01 | Przeprowadzenie prac rozwojowych i walidacyjnych nad wielowariantową protezą kolana: innowacyjne rozwiązania dla poprawy funkcjonalności i bezpieczeństwa | $391.7K$391,705 | Fundusze Europejskie dla Wielkopolski 2021-2027 | |
| 2022-02-01 | Opracowanie innowacyjnej bionicznej protezy kolana | $473.4K$473,445 | Program Operacyjny Inteligentny Rozwój | |
| 2021-03-01 | Opracowanie innowacyjnego, indywidualnie dopasowanego podciśnieniowego leja protezowego | $394.8K$394,777 | Program Operacyjny Inteligentny Rozwój |
Tenders
1 tender recorded as contractor, with a total value of $134,198.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 20, 2026 | Zakup sprzętu medycznego, komponentów protetycznych stanowiących części składowe modularnej protezy podudzia, z wykorzystaniem elektroniki i czujników do naśladowania naturalnych ruchów stopy | $134.2K$134,198 | Województwo Wielkopolskie z Siedzibą Urzędu Marszałkowskiego Województwa Wielkopolskiego w Poznaniu |
Public sector contracts
Enforce Medical Technologies is the contractor in 4 public sector contracts, worth PLN 929.50k in total. They were signed with 2 public buyers.
| Public buyer | Value | |
|---|---|---|
| Ortopedyczno-Rehabilitacyjny Szpital Kliniczny Im. Wiktora Degi Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | PLN 2,000 | |
| Ortopedyczno-Rehabilitacyjny Szpital Kliniczny Im. Wiktora Degi Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | PLN 2,500 | |
| Urząd Marszałkowski Województwa Wielkopolskiego w Poznaniu | PLN 920,000 | |
| Ortopedyczno-Rehabilitacyjny Szpital Kliniczny Im. Wiktora Degi Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | PLN 5,000 |
National Health Fund (NFZ) contracts
Enforce Medical Technologies has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Zaopatrzenie w wyroby medyczne | wielkopolskie | 1 | USD 0.00 |
Authorized Representatives
Manner of representation
The following are authorised to sign and make declarations on behalf of the company: 1. in the case of a one-person management board, the sole member of the management board acting independently; 2. in the case of a multi-member management board, at least two members of the management board acting jointly, including the Vice-President of the Management Board, if one has been appointed.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 3,922 | $52,971.37 | 34.0392% | |
Adam Eligiusz Gramala (32) | 1,216 | $16,423.55 | 10.5537% |
| 4,864 | $65,694.22 | 42.2149% | |
Piotr Krzysztof Rajewski (46) | 1,520 | $20,529.44 | 13.1922% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laboratorium Badawcze Sorbolabsp. z o.o. | $1,593,152.63 | sorbolab.pl | ||
| Centrum Alergologiisp. z o.o. | $812,503.07 | centrumalergologii.pl | ||
| Reumedikasp. z o.o. | $323,427.61 | reumedika.pl | ||
| Wielkopolskie Centrum Medycyny Podróżysp. z o.o. | $175,243.92 | medtrop.pl | ||
| Green Cenergysp. z o.o. | $47,243.84 | greencenergy.pl | ||
| EmpekoS.A. | $13,339.66 | empeko.pl | ||
| Biuro Studiów Inżynierskich Resolv3d Poznańsp. z o.o. | $3,223.34 | resolv3d.pl | ||
| Klause&StaschS.A. | $2,988.76 | klausestasch.kmpsa.net.pl | ||
| Optiliosp. z o.o. | $2,789.21 | optil.io | ||
| Empyriosp. z o.o. | $753.70 | empyrio.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-11 | Share capital change (490,300.00 PLN → 576,100.00 PLN) | |
| 2024-06-11 | PKD change (Removed: 72.11.Z) | |
| 2021-04-13 | Share capital change (380,000.00 PLN → 490,300.00 PLN) | |
| 2019-11-29 | Share capital change (5,000.00 PLN → 380,000.00 PLN) | |
| 2018-09-27 | PKD change (Added: 71.12.Z, 71.20.B, 86.90.A, 86.90.E) |
FAQ
Last updated: 2026-04-25